FDA Withdrawn Approval for Some Cholesterol Lowering Drugs
FDA Withdraw The Approval of Niacin and Fenofibric Announced in the Federal Register on April 18, 2016, the U.S. Food and Drug Administration (FDA) disclosed their decision to withdraw earlier approval of niacin and fenofibric acid in combination with statins to treat high cholesterol, according to Medscape. Affected are niacin … [Read more...] about FDA Withdrawn Approval for Some Cholesterol Lowering Drugs
Contact lens solution withdrawn
Contact Lens Solution Has Been Linked To An Eye Infection. A popular contact lens solution has been withdrawn voluntarily from the market as a result of a link between using the solution and developing an eye infection. Bausch and Lomb have withdrawn ReNU with MoistureLoc Multi-Purpose from the worldwide market following an … [Read more...] about Contact lens solution withdrawn
NeutroSpec Withdrawn From Market
NeutroSpec Withdrawn From Market. The Food and Drug Administration (FDA) has issued an alert about NeutroSpec, a diagnostic imaging agent injected into a patient's bloodstream to help doctors diagnose ailments, saying it may cause severe, life-threatening reactions in some people. The manufacturer, Palatin Technologies Inc. and … [Read more...] about NeutroSpec Withdrawn From Market
Suicide Painkiller Withdrawn
Accidental Death From Painkiller Overdose. One of Britain’s most commonly used drugs is to be withdrawn over concerns about the high risk of accidental death from slight overdose and its frequent use in suicides, The Times has learnt. Co-proxamol, prescribed to hundreds of thousands of Britons every year, is to be the subject of … [Read more...] about Suicide Painkiller Withdrawn
